Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:United_States_federal_law
|
| gptkbp:amendedBy |
gptkb:Federal_Food,_Drug,_and_Cosmetic_Act
|
| gptkbp:appliesTo |
gptkb:United_States
|
| gptkbp:containsProvision |
gptkb:Risk_Evaluation_and_Mitigation_Strategies_(REMS)
Clinical Trials Database requirements Expanded authority for FDA post-market drug safety |
| gptkbp:enactedBy |
gptkb:United_States_Congress
|
| https://www.w3.org/2000/01/rdf-schema#label |
Public Law 110-84
|
| gptkbp:officialName |
gptkb:Food_and_Drug_Administration_Amendments_Act_of_2007
|
| gptkbp:publicLawNumber |
110-85
|
| gptkbp:purpose |
to improve drug safety and regulation
to reauthorize and expand the Prescription Drug User Fee Act to reauthorize and expand the Medical Device User Fee and Modernization Act |
| gptkbp:signedBy |
gptkb:George_W._Bush
September 27, 2007 |
| gptkbp:statutesAtLargeCitation |
gptkb:121_Stat._823
|
| gptkbp:bfsParent |
gptkb:College_Cost_Reduction_and_Access_Act_of_2007
|
| gptkbp:bfsLayer |
7
|